Aptadir Therapeutics

Aptadir Therapeutics is developing a treatment for Myelodysplastic Neoplasms based on the capability of specific RNA therapeutics.

Health and bio

Aptadir Therapeutics raised $45M in a Seed round announced September 29, 2026, according to entarabi.com. Investors in that round: Angelini Ventures, CDP Venture Capital, Club degli Investitori, Crescent Enterprises, Evotec, Extend, Indaco Venture Partners, Italian Angels for Biotech, Kerna Ventures, XGEN Venture.

Founders and team

• AD
  Annalisa Di Ruscio Founder

  source: crunchbase.com
• DG
  Daniel G. Tenen Founder

  source: crunchbase.com
• MK
  Marcin Kortylewski Founder

  source: crunchbase.com
• VD
  Vittorio de Franciscis Founder

  source: crunchbase.com
• GA
  Giovanni Amabile CEO & Executive Chairman

  source: crunchbase.com

Raise history

1. September 29, 2026
   Seed · $45M
   AAngelini Ventures, CCDP Venture Capital, CClub degli Investitori, CCrescent Enterprises, EEvotec, EExtend, IIndaco Venture Partners, IItalian Angels for Biotech, KKerna Ventures, XXGEN Venture
   Source: entarabi.com

Investors

• 44BIO Capital
• AAngelini Ventures
• CCDP Venture Capital
• CClub degli Investitori
• CCrescent Enterprises
• EEvotec
• EExtend
• IIndaco Venture Partners
• IItalian Angels for Biotech
• KKerna Ventures
• XXGEN Venture

Related bio health companies

• SSharp$328K · Oct 1, 2026
• MM-BasedOct 1, 2026
• AAyna HealthOct 1, 2026
• VVytalYou$830K · Sep 30, 2026
• LLindera USSep 29, 2026
• OOrtet$500M · Sep 29, 2026
• GGoerSep 29, 2026
• FFreyyaSep 29, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/aptadir-therapeutics.